We are continuously monitoring the safety profile of our products and collaborate closely with authorities to ensure patient safety, including adequate information on gastrointestinal side effects in the label. In a statement obtained by The Hill, a spokesperson for Eli Lilly, maker of Mounjaro, said that patient safety is the companys top priority, and that they actively engage in monitoring, evaluating and reporting safety information for all our medicines, the news outlet reported.
Even the best liposomal research shows only about a 30-40% increase in blood levels.[10] That sounds decent until you compare it to effervescent delivery at 161%
PMCID: PMC5990155 ) Prez E, Martnez-Tadeo J, Callero A, Hernndez G, Rodrguez-Plata E, Garca-Robaina JC (2014) A case report of allergy to exenatide
Microvascular Research (116), 50-56